CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares traded.
CardioGenics Trading Down 100.0 %
About CardioGenics
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Further Reading
- Five stocks we like better than CardioGenics
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is Forex and How Does it Work?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
